Jonathan P. Foster, Chief Financial Officer at Moleculin Biotech, Inc. (MBRX), bought 28,986 shares at $0.69 ($20K) on 2023-12-26, disclosed to the SEC on 2023-12-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| INFU | BUY | 2015-08-18 | $3K | — | Filing → |
| INFU | BUY | 2015-06-17 | $973 | — | Filing → |
| INFU | BUY | 2015-05-18 | $13K | — | Filing → |